Rituximab Maintenance Called "New Standard" for Mantle Cell LymphomaJune 20, 2011Lymphoma & Plasma Cell Disorders
Rituximab Maintenance Called "New Standard" for Mantle Cell LymphomaJune 20, 2011Lymphoma & Plasma Cell Disorders
Chemo Length May Not Affect Survival in Some B-cell LymphomasJune 16, 2011Lymphoma & Plasma Cell Disorders
Transplant in First Remission Holds Off Progression in Non-Hodgkin's LymphomaJune 16, 2011Lymphoma & Plasma Cell Disorders
Transplant in First Remission Holds Off Progression in Non-Hodgkin's LymphomaJune 16, 2011Lymphoma & Plasma Cell Disorders
Low-Dose Irradiation Allays 93% of Gastric MALT Lymphomas at 10 YearsMay 18, 2011GastroenterologyLymphoma & Plasma Cell DisordersGastrointestinal Cancer
Rare Lymphoma Reports Continue in Young Patients on TNF Blockers April 14, 2011Lymphoma & Plasma Cell DisordersRare Diseases
FDA Keeping an Eye on New Malignancy Concerns With Lenalidomide April 11, 2011Lymphoma & Plasma Cell Disorders
NCCN Upgrades Rituximab Regimens for Follicular LymphomaMarch 23, 2011Lymphoma & Plasma Cell DisordersFollicular Lymphoma
Plastic Surgery Groups Remove Cancer-Implant Webinar After ComplaintsMarch 3, 2011Lymphoma & Plasma Cell Disorders
Rituximab Maintenance Approved in Follicular LymphomaFebruary 1, 2011Lymphoma & Plasma Cell Disorders
Rituximab Maintenance Approved in Follicular LymphomaFebruary 1, 2011Lymphoma & Plasma Cell Disorders
Rituximab Maintenance Approved in Follicular LymphomaFebruary 1, 2011Lymphoma & Plasma Cell Disorders
